The present invention concerns the use of hepcidin as a marker for
detecting inflammatory chronic diseases and especially for a differential
diagnosis to detect inflammatory chronic diseases and/or non-inflammatory
chronic diseases. The present invention also concerns a method for
detecting inflammatory chronic diseases, non-inflammatory chronic
diseases and/or acute phase reactions comprising the determination of
hepcidin.